Efficacy and Safety of Filgotinib in Methotrexate-Naive Patients with Rheumatoid Arthritis: 52-Week Results

被引：0
|
作者：
Westhovens, Rene [1 ]
Rigby, William F. C. [2 ]
van der Heijde, Desiree [3 ]
Ching, Daniel W. T. [4 ]
Stohl, William [5 ]
Kay, Jonathan [6 ]
Chopra, Arvind [7 ]
Bartok, Beatrix [8 ]
Matzkies, Franziska [8 ]
Yin, Zhaoyu [8 ]
Guo, Ying [8 ]
Tasset, Chantal [9 ]
Sundy, John S. [8 ]
Jahreis, Angelika [8 ]
Mozaffarian, Neelufar [10 ]
Messina, Osvaldo Daniel [11 ,12 ]
Landewe, Robert [13 ,14 ]
Atsumi, Tatsuya [15 ]
Burmester, Gerd [16 ]
机构：
[1] Univ Hosp Leuven, Leuven, Belgium
[2] Geisel Sch Med Dartmouth, Lebanon, NH USA
[3] Leiden Univ, Med Ctr, Leiden, Netherlands
[4] Timaru Hosp, Timaru, New Zealand
[5] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA
[6] Univ Massachusetts, Sch Med, Worcester, MA USA
[7] Ctr Rheumat Dis, Pune, Maharashtra, India
[8] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
[9] Galapagos NV, Mechelen, Belgium
[10] Ichnos Sci, Paramus, NJ USA
[11] IRO Med Ctr, Buenos Aires, DF, Argentina
[12] Cosme Argerich Hosp, Buenos Aires, DF, Argentina
[13] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[14] Zuyderland Hosp, Amsterdam, Netherlands
[15] Hokkaido Univ, Fac Med, Dept Rheumatol Endocrinol & Nephrol, Sapporo, Hokkaido, Japan
[16] Charite, Berlin, Germany
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0217
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Efficacy and Safety of Filgotinib for Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate: FINCH1 Primary Outcome Results
    Combe, Bernard
    Kivitz, Alan
    Tanaka, Yoshiya
    van der Heijde, Desiree
    Matzkies, Franziska
    Bartok, Beatrix
    Ye, Lei
    Guo, Ying
    Tasset, Chantal
    Sundy, John
    Mozaffarian, Neelufar
    Landewe, Robert B. M.
    Bae, Sang-Cheol
    Keystone, Edward
    Nash, Peter
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [32] Higher efficacy of leflunomide in methotrexate-naive patients
    Combe, B
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 189 - 189
  • [33] Filgotinib Provided Rapid and Sustained Improvements of Work Productivity and Activity in Patients With Rheumatoid Arthritis who are Methotrexate-naive: Results from the FINCH-3 Study
    Pope, Janet
    Younossi, Zobair
    Stepanova, Maria
    Gerber, Lynn
    Lee, Susan
    Hasegawa, Ken
    Hendrikx, Thijs
    Boonen, Annelies
    Combe, Bernard
    Walker, David
    Alten, Rieke
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1172 - 1173
  • [34] Final 5-Year Safety and Efficacy Results Of a Phase 3, Randomized, Placebo-Controlled Trial Of Golimumab In Methotrexate-naive Patients With Rheumatoid Arthritis
    Emery, Paul
    Fleischmann, Roy M.
    Strusberg, Ingrid
    Durez, Patrick
    Nash, Peter
    Amante, Eric
    Churchill, Melvin A.
    Park, Won
    Pons-Estel, Bernardo
    Han, Chenglong
    Gathany, Timothy A.
    Zhou, Yiying
    Xu, Stephen
    Hsia, Elizabeth C.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S188 - S189
  • [35] FINAL 5-YEAR SAFETY AND EFFICACY RESULTS OF A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF GOLIMUMAB IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS
    Emery, Paul
    Fleischmann, Roy M.
    Strusberg, Ingrid
    Durez, Patrick
    Nash, Peter
    Amante, Eric
    Churchill, Melvin
    Park, W.
    Pons-Estel, Bernardo
    Han, Chenglong
    Gathany, Tim
    Zhou, Yiying
    Xu, Stephen
    Hsia, Elizabeth C.
    RHEUMATOLOGY, 2014, 53 : 93 - 93
  • [36] BIMEKIZUMAB EFFICACY AND SAFETY IN BIOLOGIC DMARD- NAIVE PATIENTS WITH PSORIATIC ARTHRITIS WAS CONSISTENT WITH OR WITHOUT METHOTREXATE: 52-WEEK RESULTS FROM THE PHASE 3 ACTIVE-REFERENCE STUDY BE OPTIMAL
    Mcinnes, I.
    Mease, P. J.
    Tanaka, Y.
    Behrens, F.
    Gossec, L.
    Husni, M. E.
    Kristensen, L. E.
    Warren, R. B.
    Ink, B.
    Bajracharya, R.
    Coarse, J.
    Eells, J.
    Gottlieb, A. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1133 - 1134
  • [37] Efficacy and Safety of Apremilast in Systemic- and Biologic-Naive Patients With Moderate Plaque Psoriasis: 52-Week Results of UNVEIL
    Gold, Linda Stein
    Bagel, Jerry
    Lebwohl, Mark
    Jackson, J. Mark
    Chen, Rongdean
    Goncalves, Joana
    Levi, Eugenia
    Duffin, Kristina Collis
    JOURNAL OF DRUGS IN DERMATOLOGY, 2018, 17 (02) : 221 - 228
  • [38] UPADACITINIB MONOTHERAPY IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 72 WEEKS FROM SELECT-EARLY
    Van Vollenhoven, R.
    Takeuchi, T.
    Rischmueller, M.
    Blanco, R.
    Xavier, R.
    Howard, M.
    Friedman, A.
    Song, Y.
    Strand, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 330 - 331
  • [39] Tofacitinib Monotherapy Versus Methotrexate in Methotrexate-Naive Patients with Rheumatoid Arthritis: Radiographic, Clinical and Functional Comparison
    Fleischmann, R. M.
    Lee, E. B.
    Hall, S.
    Wilkinson, B. E.
    Bradley, John D.
    Gruben, D.
    Koncz, T.
    Krishnaswami, S.
    Wallenstein, G.
    Zwillich, S. H.
    van Vollenhoven, R. F.
    ARTHRITIS AND RHEUMATISM, 2013, 65 (12): : 3323 - 3323
  • [40] A MULTICENTER RANDOMIZED STUDY IN RHEUMATOID ARTHRITIS TO COMPARE IGURATIMOD, METHOTREXATE, OR COMBINATION: 52 WEEK EFFICACY AND SAFETY RESULTS OF THE SMILE TRIAL
    Du, F.
    Xu, J.
    Li, X.
    Li, Z.
    Li, X.
    Zuo, X.
    Bi, L.
    Zhao, D.
    Zhang, M.
    Wu, H.
    He, D.
    Wu, Z.
    Li, Z.
    Li, Y.
    Xu, J.
    Tao, Y.
    Zhao, J.
    Chen, J.
    Zhang, H.
    Li, J.
    Jiang, L.
    Xiao, Z.
    Chen, Z.
    Yin, G.
    Gong, L.
    Wang, G.
    Dong, L.
    Xiao, W.
    Bao, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 574 - 575
12345